About PD Neurotechnology
PD Neurotechnology is a company based in London (United Kingdom) founded in 2015 by Dimitris Fotiadis, Nikos Moschos, Spyridon Konitsiotis, and Tassos Manos. PD Neurotechnology has raised $93.34 million across 8 funding rounds from investors including SeedBlink, National Bank of Greece and Onassis Foundation. PD Neurotechnology offers products and services including PDMonitor®. PD Neurotechnology operates in a competitive market with competitors including Empatica, Openwater, iota Biosciences, Magnus Medical and MindAffect, among others.
- Headquarter London, United Kingdom
- Founders Dimitris Fotiadis, Nikos Moschos, Spyridon Konitsiotis, Tassos Manos
- Stage Minicorn
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pd Neurotechnology Limited
- Date of Incorporation 30 Sep, 2015
- Jurisdiction LONDON
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$93.34 M (USD)
in 8 rounds
-
Latest Funding Round
$2.97 M (USD), Series A
Apr 25, 2023
-
Investors
SeedBlink
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PD Neurotechnology
PD Neurotechnology offers a comprehensive portfolio of products and services, including PDMonitor®.
Wearable system for tracking Parkinson's symptoms and aiding patient care.
Funding Insights of PD Neurotechnology
PD Neurotechnology has successfully raised a total of $93.34M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $2.97 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PD Neurotechnology
PD Neurotechnology has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include SeedBlink, National Bank of Greece and Onassis Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A multi-stage technology investment platform is operated globally.
|
Locked | Locked | Locked | |
|
CIC Partners is engaged in middle-market private equity investments.
|
Locked | Locked | Locked | |
|
Non-profit organization that fosters art, culture, education, and health initiatives through various programs, residencies, and fellowships, promoting creativity, innovation, and social impact
|
Locked | Locked | Locked |
Investor details for PD Neurotechnology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PD Neurotechnology
Investment portfolio details for PD Neurotechnology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PD Neurotechnology
Detailed financials for PD Neurotechnology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pd Neurotechnology Comparisons
Peer comparison for PD Neurotechnology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PD Neurotechnology
PD Neurotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Empatica, Openwater, iota Biosciences, Magnus Medical and MindAffect, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a wrist band to monitor physiological signals
|
|
| Locked | Locked | Locked |
Provider of imaging technologies for medical diagnosis and treatments
|
|
| Locked | Locked | Locked |
Developer of neurodiagnostic techniques
|
|
| Locked | Locked | Locked |
Non-invasive neuromodulation systems for depression treatment are provided.
|
|
| Locked | Locked | Locked |
Brain-computer interface headsets are developed for patient communication.
|
Detailed competitors of PD Neurotechnology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pd Neurotechnology
Complete news archive for PD Neurotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PD Neurotechnology
PD Neurotechnology was founded in 2015 and raised its 1st funding round 1 year after it was founded.
PD Neurotechnology is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
PD Neurotechnology is a funded company, having raised a total of $93.34M across 8 funding rounds to date.
PD Neurotechnology was established in 2015 in London, United Kingdom, within the health technology sector. A home-based wearable device is provided for Parkinsons patients to capture kinematic data on motor symptoms and movement disorders. This data is processed via a cloud platform, allowing physicians to review trends, assess disease progression, and recommend tailored treatment plans based on collected metrics.
PD Neurotechnology's top competitors include Empatica, Openwater and iota Biosciences.
PD Neurotechnology offers PDMonitor®.
PD Neurotechnology has 6 investors. Key investors include SeedBlink, National Bank of Greece, Onassis Foundation, Crimson International Investment, and Big Pi Ventures.
The valuation of PD Neurotechnology is $14.71M as of Jun 2021.